DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Synergy CHC Corp.

OTCPK:SNYR.Q Stock Report

Market Cap: US$804.6k

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Synergy CHC Future Growth

Future criteria checks 1/6

Synergy CHC is forecast to grow earnings and revenue by 145.1% and 14.9% per annum respectively while EPS is expected to grow by 148.4% per annum.

Key information

145.1%

Earnings growth rate

148.44%

EPS growth rate

Personal Products earnings growth27.2%
Revenue growth rate14.9%
Future return on equityn/a
Analyst coverage

Low

Last updated10 Jun 2026

Recent future growth updates

Recent updates

User avatar
Narrative Update • Jun 26

SNYR: Higher Discount Rate Will Shape Outlook Despite Nasdaq Listing Risk

Analysts have reset their price target on Synergy CHC to $3.75 from $6, reflecting a higher $12.46 discount rate, more conservative forecasts for revenue growth and profit margins, and a higher assumed future P/E of 35.70 based on recent sector research trends. Analyst Commentary Street research around the broader specialty pharma and biotech space gives some useful context for how analysts might be thinking about Synergy CHC, especially when it comes to execution risk, research outcomes, and how those factors can feed into valuation multiples and discount rates.
User avatar
New Narrative • Mar 05

Cautious On Beverage Rollout And DSD Costs Yet Expecting Healthier Margins Ahead

Catalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Feb 17

Brain Health And Clean Energy Trends Will Support Long Term Undervaluation Thesis

Catalysts About Synergy CHC Synergy CHC develops and sells FOCUSfactor branded brain health supplements and functional beverages across retail, convenience and international channels. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Feb 03

Rapid Retail Expansion And Direct Store Distribution Will Transform Long Term Earnings Power

Catalysts About Synergy CHC Synergy CHC develops and markets FOCUSfactor branded cognitive health supplements and functional energy and brain health beverages across retail and international channels. What are the underlying business or industry changes driving this perspective?
Analysis Article • Jan 28

Investors Aren't Buying Synergy CHC Corp.'s (NASDAQ:SNYR) Earnings

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...
Analysis Article • Nov 20

Should You Think About Buying Synergy CHC Corp. (NASDAQ:SNYR) Now?

Synergy CHC Corp. ( NASDAQ:SNYR ), is not the largest company out there, but it saw a decent share price growth of 18...
Analysis Article • Aug 27

Synergy CHC's (NASDAQ:SNYR) Problems Go Beyond Poor Profit

Synergy CHC Corp.'s ( NASDAQ:SNYR ) lackluster earnings announcement last week disappointed investors. We think that...

Earnings and Revenue Growth Forecasts

OTCPK:SNYR.Q - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027362N/A-31
12/31/202632-3N/A01
3/31/202628-16-4-4N/A
12/31/202530-12-3-3N/A
9/30/2025353-7-7N/A
6/30/2025343-5-5N/A
3/31/2025342-5-5N/A
12/31/2024352-5-5N/A
9/30/202438522N/A
6/30/202441511N/A
3/31/202444711N/A
12/31/202343600N/A
12/31/202238-33-8-8N/A
9/30/202147412N/A
6/30/202147322N/A
3/31/202146200N/A
12/31/2020401-2-2N/A
9/30/202036-9-2-2N/A
6/30/202031-10-1-1N/A
3/31/202026-1011N/A
12/31/201929-9N/A3N/A
9/30/201928-4N/A2N/A
6/30/201930-4N/A2N/A
3/31/201934-5N/A1N/A
12/31/201834-6N/A1N/A
9/30/201835-3N/A0N/A
6/30/201835-3N/A-3N/A
3/31/201835-2N/A-2N/A
12/31/2017360N/A-1N/A
9/30/201736-4N/A1N/A
6/30/201738-1N/A6N/A
3/31/201737-1N/A4N/A
12/31/201635-1N/A6N/A
9/30/2016341N/A5N/A
6/30/201626-2N/A3N/A
3/31/201620-2N/A2N/A
12/31/201513-8N/A-1N/A
9/30/20157-3N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SNYR.Q is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SNYR.Q is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SNYR.Q is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SNYR.Q's revenue (14.9% per year) is forecast to grow faster than the US market (13.6% per year).

High Growth Revenue: SNYR.Q's revenue (14.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SNYR.Q's Return on Equity is forecast to be high in 3 years time


Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 08:34
End of Day Share Price 2026/09/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Synergy CHC Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide